CTLA4 and neoplasm: Another study was conducted to test whether the relationship between the response to CTLA-4 monoclonal antibodies and the gut microbiome was the same as that in anti-PD1 therapy and it was found that Bacteroidales play a key role in the effects of tumour immunity induced by the blockade of CTLA-4 [41].